Pacs (PACS) EBITDA Margin (2023 - 2026)

Pacs (PACS) posted EBITDA Margin of 8.45% for Q1 2026, up 21.17% sequentially from 6.97% in Q4 2025, and up 468.0% YoY from 1.49% in Q1 2025.

Pacs (PACS) EBITDA Margin (2023 - 2026) Analysis & Trends

Pacs has reported EBITDA Margin for 4 years, with the latest figure at 8.45% in Q1 2026.

Quarterly EBITDA Margin rose 468.0% year-over-year to 8.45% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.02% (up 464.0% YoY) and the FY2025 annual result came in at 5.85%, up 284.0% from the prior year.
EBITDA Margin advanced to 8.45% in Q1 2026 per PACS's latest filing, from 6.97% in the prior quarter.
Over five years, EBITDA Margin peaked at 8.45% in Q1 2026 and troughed at 3.97% in Q2 2024.
A 4-year average of 5.38% and a median of 6.42% in 2025 frame the typical range for EBITDA Margin.
The sharpest annual moves came in 2024 and 2025: EBITDA Margin tumbled 1049 bps in 2024, then jumped 1012 bps in 2025.
Over 4 years, EBITDA Margin stood at 7.34% in 2023, then declined by 19 bps to 5.96% in 2024, then climbed by 17 bps to 6.97% in 2025, then increased by 21 bps to 8.45% in 2026.
According to Business Quant data, EBITDA Margin over the past three periods registered 8.45%, 6.97%, and 6.42% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	HCA Healthcare	88.19 Bn	90.61 Bn	15.19 Bn	-12.60%
2	Tenet Healthcare	21.59 Bn	21.56 Bn	4.45 Bn	26.67%
3	Encompass Health	12.19 Bn	12.86 Bn	1.34 Bn	2.10%
4	Davita	11.52 Bn	12.39 Bn	1.16 Bn	16.29%
5	Ensign	10.59 Bn	10.27 Bn	306.24 Mn	8.50%
6	Universal Health Services	8.79 Bn	8.72 Bn	3.29 Bn	11.14%
7	Pacs	7.04 Bn	6.88 Bn	338.46 Mn	7.66%
8	Chemed	6.96 Bn	6.92 Bn	221.47 Mn	13.25%
9	Concentra Group Holdings Parent	4.52 Bn	4.38 Bn	192.10 Mn	18.99%
10	Option Care Health	3.59 Bn	3.39 Bn	267.25 Mn	5.90%

Download Data